663 related articles for article (PubMed ID: 15542666)
1. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
Peltoniemi J; Broberg EK; Nygårdas M; Erälinna JP; Waris M; Hukkanen V
Int Immunopharmacol; 2006 May; 6(5):817-29. PubMed ID: 16546713
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.
Peltoniemi J; Broberg EK; Halenius A; Setala N; Eralinna JP; Salmi AA; Roytta M; Hukkanen V
Clin Exp Immunol; 2004 Aug; 137(2):305-12. PubMed ID: 15270847
[TBL] [Abstract][Full Text] [Related]
4. Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis.
Broberg E; Setälä N; Röyttä M; Salmi A; Erälinna JP; He B; Roizman B; Hukkanen V
Gene Ther; 2001 May; 8(10):769-77. PubMed ID: 11420640
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
6. IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitis.
Broberg EK; Salmi AA; Hukkanen V
Neurosci Lett; 2004 Jul; 364(3):173-8. PubMed ID: 15196670
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems.
Tal-Singer R; Pichyangkura R; Chung E; Lasner TM; Randazzo BP; Trojanowski JQ; Fraser NW; Triezenberg SJ
Virology; 1999 Jun; 259(1):20-33. PubMed ID: 10364486
[TBL] [Abstract][Full Text] [Related]
8. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
9. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice.
Broberg EK; Setälä N; Erälinna JP; Salmi AA; Röyttä M; Hukkanen V
J Interferon Cytokine Res; 2002 Jun; 22(6):641-51. PubMed ID: 12162874
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
Drescher KM; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
[TBL] [Abstract][Full Text] [Related]
12. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
13. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
Valyi-Nagy T; Gesser RM; Raengsakulrach B; Deshmane SL; Randazzo BP; Dillner AJ; Fraser NW
Virology; 1994 Mar; 199(2):484-90. PubMed ID: 8122378
[TBL] [Abstract][Full Text] [Related]
14. Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.
Mogensen TH; Melchjorsen J; Malmgaard L; Casola A; Paludan SR
J Virol; 2004 Jun; 78(11):5883-90. PubMed ID: 15140986
[TBL] [Abstract][Full Text] [Related]
15. Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2001 Oct; 75(19):9029-36. PubMed ID: 11533166
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
17. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
[TBL] [Abstract][Full Text] [Related]
19. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
20. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H
Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
